Halterman Jill S, Auinger Peggy, Conn Kelly M, Lynch Kathleen, Yoos H Lorrie, Szilagyi Peter G
Department of Pediatrics, University of Rochester School of Medicine and Dentistry and the Children's Hospital at Strong, Rochester, NY 14642, USA.
Ambul Pediatr. 2007 Mar-Apr;7(2):153-9. doi: 10.1016/j.ambp.2006.11.007.
Asthma continues to cause significant morbidity in children. We hypothesized that many children still do not use recommended preventive medications, or they have ineffective symptom control despite preventive medication use. The aim of this study was 1) to describe the use of preventive medications among children with persistent asthma, 2) to determine whether children using preventive medications have adequate asthma control, and 3) to identify factors associated with poor control.
The State and Local Area Integrated Telephone Survey (SLAITS) Asthma Survey provided parent-reported data for children aged <18 years with asthma from a random-digit dial survey implemented in Alabama, California, Illinois, and Texas. We focused this analysis on children with persistent symptoms and/or children using preventive asthma medications (N = 975). Children with inadequate therapy had persistent symptoms and no preventive medication use. Children with suboptimal control had persistent symptoms or > 1 attack in the previous 3 months despite preventive medication use; children in optimal control had intermittent symptoms, < or = 1 attack, and reported using preventive medication. Demographic and asthma-related variables were compared across groups.
Among children with persistent asthma, 37 per cent had inadequate therapy, 42.9 per cent had suboptimal control, and only 20.1 per cent had optimal control. In multivariate regression, black race (odds ratio [OR], 2.0; 95 percent confidence interval [CI] 1.1-3.5), Hispanic ethnicity (OR, 1.8; 95 per cent CI, 1.1-2.9), and discontinuous insurance status (OR, 2.4; 95 per cent CI, 1.4-4.3) were associated with inadequate therapy. Potential explanations for poor control included poor adherence, exposure to smoke and other triggers, and lack of written action plans.
Inadequate asthma therapy remains a significant problem. A newly highlighted concern is the substantial number of children experiencing poor symptom control despite reported use of preventive medications.
哮喘持续给儿童带来严重的发病情况。我们推测,许多儿童仍未使用推荐的预防性药物,或者尽管使用了预防性药物,但其症状控制效果不佳。本研究的目的是:1)描述持续性哮喘儿童预防性药物的使用情况;2)确定使用预防性药物的儿童哮喘控制是否充分;3)识别与控制不佳相关的因素。
州和地方综合电话调查(SLAITS)哮喘调查提供了来自阿拉巴马州、加利福尼亚州、伊利诺伊州和得克萨斯州通过随机数字拨号调查获得的18岁以下哮喘儿童家长报告的数据。我们将该分析聚焦于有持续性症状的儿童和/或使用预防性哮喘药物的儿童(N = 975)。治疗不足的儿童有持续性症状且未使用预防性药物。控制不佳的儿童尽管使用了预防性药物,但仍有持续性症状或在过去3个月内发作超过1次;控制良好的儿童有间歇性症状、发作≤1次,并报告使用了预防性药物。对各亚组的人口统计学和哮喘相关变量进行比较。
在持续性哮喘儿童中,37%的儿童治疗不足,42.9%的儿童控制不佳,只有20.1%的儿童控制良好。在多变量回归分析中,黑人种族(比值比[OR],2.0;95%置信区间[CI] 1.1 - 3.5)、西班牙裔(OR,1.8;95% CI,1.1 - 2.9)和间断性保险状态(OR,2.4;95% CI,1.4 - 4.3)与治疗不足相关。控制不佳的潜在原因包括依从性差、接触烟雾和其他触发因素以及缺乏书面行动计划。
哮喘治疗不足仍然是一个重大问题。一个新出现的突出问题是,尽管报告使用了预防性药物,但仍有相当数量的儿童症状控制不佳。